Global Markets Directs, Cleveland BioLabs, Inc. (NASDAQ:CBLI), provides an overview of the Cleveland BioLabs, Inc.s pharmaceutical research and development focus. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from … Continue reading Stocks in news: Cleveland BioLabs, Inc. (NASDAQ:CBLI), Intel Corporation (NASDAQ:INTC), American Woodmark Corp. (NASDAQ:AMWD), Tootsie Roll Industries (NYSE:TR), United States Cellular (NYSE:USM)